News
Dr. Chigbo Joshua Agogbuo is the CEO/Founder of WholeShield Pharmaceuticals, a brand committed to revolutionising healthcare ...
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK ® ...
Keranique, America's #1 hair regrowth system for women, is proud to announce its partnership with The Content Creator Idol - a global online singing competition created by Teresa Murphy. This ...
Dr. Agogbuo Chigbo Joshua is a pharmacist, serial entrepreneur, and the CEO and Founder of WholeShield Pharmaceuticals—a ...
Artwork in children’s books brings layers to the story and does the work of capturing the big, small moments in kids’ lives, ...
Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 ...
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4%Total Rare Disease quarterly net revenues of $69.0 million, which includes:Purified Cortrophin® Ge ...
Hosted on MSN25d
Dentistry in the Middle AgesTry to imagine it in the Middle Ages without anesthetic and with no sophisticated dental tools. Any affliction of the teeth meant a trip to the barber surgeon, who was the go-to medical ...
The election process in the early Middle Ages was quite transparent and collegial: Early popes were selected by consensus by the Roman deacons and nearby bishops, who then presented the pope-elect ...
MedievalMadness on MSN4d
Alchemy in Medieval Times – Between Science and SorceryAlchemy in the Middle Ages was more than just the pursuit of gold – it was a blend of science, mysticism, and philosophy that captured the imagination of scholars across Europe. In this episode, we ...
The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results